Online Inquiry
Diagnostic Development Service for Prostate Cancer
The diagnosis of prostate cancer is a growing field. It plays a crucial role in ensuring the appropriate therapeutic options are offered. Alfa Cytology focuses on diagnostic development services in the field of prostate cancer and aims to provide customers with comprehensive one-stop diagnostic development services.
Introduction to Prostate Cancer Diagnostics
Prostate cancer screening refers to the testing of a wide range of asymptomatic men by means of serum prostate-specific antigen (PSA) tests and rectal examination (DRE) with a view to early detection, early diagnosis, and early therapy of the disease, with a view to reducing the mortality rate from prostate cancer.
Prostate cancer (PCa) is the second most common cancer, with approximately 1.46 million new cases as of 2022 worldwide. Despite its relatively optimistic 5-year prognosis, prostate cancer remains one of the leading causes of cancer deaths in men, with approximately 397,430 prostate cancer deaths worldwide in 2022.
Classification of Prostate Cancer Diagnostics
Prostate Specific Antigen (PSA) Test
PSA levels are measured in blood samples to diagnose prostate cancer.
Diagnostic Rectal Examination (DRE)
The prostate is examined by palpation for size, shape and the presence of hard lumps.
Imaging Tests
Rectal ultrasound (TRUS) or multiparametric magnetic resonance imaging (mpMRI) was used to detect suspicious lesions and localize them for diagnosis.
Puncture Biopsy of the Prostate
Obtaining a tissue sample through a puncture biopsy is the gold standard for confirming a diagnosis of prostate cancer.
Importance of Prostate Cancer Diagnostics
Early diagnosis of prostate cancer is critical to improving survival and quality of life.
- Improving Survival
Early detection of prostate cancer is critical to improving survival. Regular medical checkups and timely screenings can help detect the disease at an early stage, allowing for more effective therapy. It is reported that the survival rate of prostate cancer patients with early detection can reach 100%, while the 5-year survival rate of patients with advanced stages is drastically reduced to 31%.
- Hidden symptoms
Early prostate cancer can be cured by simple radical therapy, but as prostate cancer has no obvious symptoms in the early stage, when obvious symptoms appear, the best therapy period is often missed, so early diagnosis of prostate cancer is very important for finding asymptomatic patients.
Our Services
We are committed to continually advancing the development of prostate cancer diagnostics with the goal of providing safer, more effective, and more personalized diagnostic solutions. Our mission is to develop novel diagnostic methods for prostate cancer through scientific innovation. Alfa Cytology can provide one-stop prostate cancer diagnostic development services.
Our Advantages
We are committed to providing efficient, innovative and reliable development solutions by leveraging our in-depth professional knowledge, adopting cutting-edge technologies, and enforcing strict quality control standards.
Professional Knowledge
Cutting-Edge Technologies
Quality Control
By partnering with us, you will receive personalized consulting services and efficient project advancement to make your diagnostic development journey smoother and more successful. If you are interested in our services, please don't hesitate to contact us for further information and pricing details.
For research use only.